2 Biotech Cos. Raise $111M Combined In Low-Priced IPOs
Law360 (May 23, 2019, 5:42 PM EDT) -- Two venture-backed biotechnology firms developing cancer therapies went public Thursday after raising a combined $111 million in initial public offerings that priced at the bottom of or below their projected ranges during a choppy period for stocks.
U.K. oncology company Bicycle Therapeutics Ltd., advised by Goodwin Procter LLP, raised $61 million after selling 4.3 million shares at $14 each, representing the bottom of its range of $14 to $16.
South San Francisco-based drug developer Ideaya Biosciences Inc., advised by Latham & Watkins LLP, raised $50 million after selling 5 million shares at $10 each, below the company’s forecasted range of $13...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!